Abstract:
Quality of life in patients with breast cancer is an important outcome. This chapter presents an overview of the literature on the topic ranging from descriptive findings to clinical trials. There is quite an extensive body of the literature on quality of life in breast cancer patients. Studies on quality of life in breast cancer have made a considerable contribution in improving breast cancer care, although their exact benefit is hard to define. Quality of life data in breast cancer patients provided scientific evidence for clinical decision-making and conveyed helpful information concerning breast cancer patients’ experiences during the course of the disease diagnosis, treatment, disease-free survival time, and recurrences; otherwise finding solutions for evidence-based selection of optimal treatments, psychosocial interventions, patient–physician communications, allocation of resources, and indicating research priorities were impossible. More qualitative research is needed for a better understanding of the topic. In addition, issues related to the disease, its treatment side effects and symptoms, and sexual functioning should receive more attention when studying quality of life in breast cancer patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- A:
-
doxorubcin
- ALND:
-
axillary lymph node dissection
- ANA:
-
anastrozole
- BCPT-BESS:
-
breast cancer prevention trial eight symptom scale
- BCPT-SCL:
-
BCPT symptom checklist
- BCQ:
-
breast cancer chemotherapy questionnaire
- BCS:
-
breast conservation surgery
- BI:
-
body image
- BIBCQ:
-
body image after breast cancer questionnaire
- C:
-
cyclophosphamide
- CTCb:
-
cyclophosphamide, thiotepa, and carboplatin
- DPPE:
-
tesmilifene
- E:
-
epirubcin
- EORTC QLQ-BR23:
-
European Organization for Research and Treatment of Cancer breast cancer specific quality of life questionnaire
- EXE:
-
exemestane
- F:
-
5-fluorouracil
- FACT-B:
-
functional assessment of cancer therapy breast cancer specific questionnaire
- FACT-B+4:
-
impact of arm morbidity subscale for FACT-B
- FACT-B-plus ES:
-
an endocrine symptom subscale for the FACT-B
- FACT-G:
-
functional assessment of cancer therapy-general
- FSAQ:
-
Fallowfield’s sexual activity questionnaire
- FU:
-
future perspective
- G-CSF:
-
granulocyte colony stimulating factor
- HADS:
-
hospital anxiety and depression scale
- LASA:
-
linear analogue self-assessment
- LSQ-32:
-
life satisfaction questionnaire
- M:
-
methotrexate
- MAS:
-
mastectomy
- MRM:
-
modified radical mastectomy
- PTSD:
-
post-traumatic distress disorder
- QLACS:
-
quality of life in adult cancer survivors
- QOL:
-
quality of life
- RSC:
-
Rotterdam symptom checklist
- SEE:
-
sexual enjoyment
- SEF:
-
sexual functioning
- SF-36:
-
medical outcomes study short form survey
- SLDS-BC:
-
satisfaction with life domains scale for breast cancer
- SNLB:
-
sentinel lymph node biopsy
- T:
-
docetaxel
- TAM:
-
tamoxifen
References
Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Ttius-Ernstoff L, Skalla K, Bakitas M, Silberfarb PM. (2005). J Clin Oncol. 23: 4399–4405.
Amir M, Ramati A. (2002). J Anxiety Disord. 16: 191–206.
Antoni MH, Lechner SC, Kazi A, Wimberly SR, Sifre T, Urcuyo KR, Phillips K, Gluck S, Carver CS. (2006). J Consult Clin Psychol. 74: 1143–1152.
Arndt V, Stegmaier C, Ziegler H, Brenner H. (2006). Cancer. 107: 2496–2503.
Ashing-Giwa K. (1999). J Psychosoc Oncol. 17: 47–62.
Atkins L, Fallowfield LJ. (2007). Menopause Int. 13: 103–109.
Avis NE, Crawford S, Manuel J. (2005). J Clin Oncol. 23: 3322–3330.
Avis NE, Foley KL. (2006). Health Qual Life Outcomes. 4: 92.
Badger TA, Braden CJ, Mishel MH, Longman A. (2004). Res Nurs Health. 27: 19–28.
Baucom DH, Porter LS, Kiby JS, Gremore TM, Keefe FJ. (2006). Breast Dis. 23: 103–113.
Baxter NN, Goodwin PJ, Mcleod RS, Dion R, Devins G, Bombardier C. (2006). Breast J. 12: 221–232.
Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. (2002). Arch Surg. 137: 1253–1257.
Beckjord E, Campas BE. (2007). J Psychosoc Oncol. 25: 19–36.
Bernhard J, Zahrieh D, Coates AS, Gelber R, Castiglione-Gertsch M, Murray E, Forbes JF, Perey L, Collins J, Snyder R, Rudenstam CM, Crivellari D, Veronesi A, Thurlimann B, Fey MF, Price KN, Goldhirsch A, Hurny C. (2004). Br J Cancer. 91: 1893–1901.
Bloom JR, Stewart SL, Johnston M, Banks P. (1998). Psycho-Oncol. 7: 89–100.
Bordeleau L, Szalai JP, Ennis M, Leszcz M, Speca M, Sela R, Doll R, Chochinov HM, Navarro M, Arnold A, Pritchard KI, Bezjak A, Liewellyn-Thomas HA, Sawka CA, Goodwin PJ. (2003). J Clin Oncol. 21: 1944–1951.
Bottomley A, Biganzoli L, Cufer T, Coleman RE, Coens C, Efficace F, Calvert HA, Gamucci T, Twelves C, Fargeot P, Piccart M. (2004). J Clin Oncol. 22: 257–286.
Bottomley A, Therasse P. (2002). Lancet Oncol. 3: 620–628.
Bottomley A, Therasse P, Piccart M, Efficace F, Coens C, Gotay C, Welnicka-Jaskiewicz M, Mauriac L, Dyczka J, Cufer T, Lichinitser MR, Schornagel JH, Bonnefoi H, Shepherd L. (2005). Lancet Oncol. 6: 287–294.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyetowitz BE, Belin TR. (2000). J Clin Oncol. 18: 743–753.
Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G. (1997). J Clin Oncol. 15: 974–986.
Burckhardt CS, Carol S, Jones KD. (2005). Health Qual Life Outcomes. 3: 30.
Byar KL, Berger AM, Bakken SL, Cetak MA. (2006). Oncol Nurs Forum. 33: E18–E26.
Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E. (2003). Breast Cancer Res Treat. 80: 39–48.
Carlsson M, Hamrin E. (1996). Qual Life Res. 5: 265–274.
Carpenter JS. (2001). J Pain Symptom Manag. 22: 979–989.
Carpenter JS, Andrykowski MA, Cordova M, Cunningham L, Studts J, McGrath P, Kenady D, Sloan D, Munn R. (1998). Cancer. 82: 1682–1691.
Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A. (2006). Breast Cancer Res Treat. 100: 273–284.
Cella D, Fallowfield LJ. (2008). Breast Cancer Res Treat. 107: 167–180.
Cella D, Land SR, Chang CH, Day R, Costantino JP, Wolmark N, Ganz PA. (2008). Breast Cancer Research Treat. 109: 515–526.
Chie WC, Chang KJ, Huang CS, Kuo WH. (2003). Psychooncology. 12: 729–735.
Coates A, Gebski V, Bishop JF, Jeal PN, Woods RL, Snyder R, Tattersall MH, Byrne M, Harvey V, Gill G. (1987). N Engl J Med. 317: 1490–1495.
Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byne M, Forbes JF. (1992). J Clin Oncol. 10: 1833–1838.
Coates AS, Hurny C, Peterson HF, Bernhard J, Castinglione-Gertsch M, Gelberg D, Goldhirsch A. (2000). J Clin Oncol. 18: 3768–3774.
Conde DM, Pinto-Neto AM, Cabello C, Santos-Sa D, Costa-Paiva L, Martinze EZ. (2005). Menopause. 12: 436–443.
Costanzo ES, Lutgendorf SK, Mattes ML, Trehan S, Robinson CB, Tewfik F, Roman SL. (2007). Br J Cancer. 97: 1625–1631.
Coster S, Poole K, Fallowfield LJ. (2001). Breast Cancer Res Treat. 68: 273–282.
Cotton SP, Levine EG, Fitzpatrick CM, Dold KH, Targ E. (1999). Psychooncology. 8: 429–438.
de Haes H, Olschewski M, Kaufmann M, Schumacher M, Jonat W, Sauerbrei W. (2003). J Clin Oncol. 21: 4510–4516.
de Haes JC, Olschewski M. (1998). Ann Oncol. 9: 745–750.
Deshields T, Tibbs T, Fan MY, Bayer L, Taylor M, Fisher E. (2005). Support Care Cancer. 13: 1018–1026.
Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B. (1998). J Clin Oncol. 16: 487–494.
Efficace F, Biganzoli L, Piccart M, Coens C, van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A. (2004a). Eur J Cancer. 40: 1021–1030.
Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Srangers MA, Bottomley A. (2004b). J Clin Oncol. 22: 3381–3388.
Elder EE, Brandberg Y, Bjorklund T, Rylander R, Lagergren J, Jurell G, Wickman M, Sandelin K. (2005). Breast. 14: 201–208.
Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Halzel D. (2004). Breast J. 10: 223–231.
Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. (2003). Breast Cancer Res Treat. 79: 47–57.
Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howll A. (2004). J Clin Oncol. 22: 4261–4271.
Fallowfield LJ, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coobes RC, Hall E. (2006). J Clin Oncol. 24: 910–917.
Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. (1999). Breast Cancer Res Treat. 55: 189–199.
Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE. (2006). Breast Cancer Res Treat. 95: 279–293.
Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence H. (2002). J Pain Symptom Manag. 24: 471–480.
Fossati R, Confalonieri C, Mosconi P, Pistotti V, Apolone G. (2004). Breast Cancer Res Treat. 87: 233–243.
Fraser SCA, Ramirez AJ, Ebbes SR, Fallowfield LJ, Dobbs HJ, Richards MA, Bates T, Baum M. (1993). Br J Cancer. 67: 341–346.
Galalae RM, Michel J, Siebmann JU, Kuchler T, Eilf K, Kimmig B. (2005). Strahlenther Onkol (Strahlentherapie und Onkologie). 181: 645–651.
Ganz PA, coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. (1996). Breast Cancer Res Treat. 38: 183–199.
Ganz PA, Goodwin PJ. (2005). In: Lipscomb J, Gotay CC, Snyder C (ed.) Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge University Press, Cambridge, UK, pp. 93–125.
Ganz PA, Guadagnoli E, Landdrum MB, Lash TL, Rakowski W, Silliman RA. (2003). J Clin Oncol. 21: 4027–4033.
Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR. (2004). J Natl Cancer Inst. 96: 376–387.
Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. (1998). J Clin Oncol. 16: 501–514.
Girotto JA, Schreiber J, Nahabedian MY. (2003). Ann Plast Surg. 50: 572–578.
Golden-Kreutz DM, Thornton LM, Wells-Di GS, Frierson GM, Jim HS, Carpenter KM, Shelby RA, Andersen BL. (2005). Health Psychol. 24: 288–296.
Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. (2003). J Natl Cancer Inst. 95: 263–281.
Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KT, Trudeau Me, Koo J, Hood N. (2004). J Clin Oncol. 22: 4184–4192.
Grabsch B, Clarke DM, Love A, McKenzie DP, Snyder RD, Bloch S, Smith G, Kissane DW. (2006). Palliat Support Care. 4: 47–56.
Grimison PS, Stockler M. (2007). Expert Rev Anticancer Ther. 7: 1123–1134.
Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. (2007). Breast Cancer Res Treat. 105: 209–219.
Gupta P, Sturdee DW, Pallin SL, Majumder K, Fear R, Marshall T, Paterson I. (2006). Climacteric. 9: 49–58.
Hann DM, Garovoy N, Finkelstein B, Jacobsen PB, Azzarello LM, Fields KK. (1999). J Pain Symptom Manage. 17: 313–319.
Hann DM, Jacobson P, Martin S. (1998). J Clin Psychol Med S. 5: 19–33.
Heidrich SM, Egan JJ, Hengudomsub P, Randolph SM. (2006). Oncol Nurs Forum. 33: 315–322.
Hopwood P, Haviland J, Mills J, Sumo G, Bliss MJ. (2007). Breast. 16: 241–251.
Irwig L, Bennetts A. (1997). Aust N Z J Surg. 67: 750–754.
Janni W, Rjosk D, Dimpfl T, Haertl K, Strobl B, Hepp F, Hanke A, Bergauer F, Sommer H. (2001). Ann Surg Oncol. 8: 542–548.
Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ. (2007). J Women’s Health. 16: 1348–1361.
Karamouzis MV, Ioannidis G, Rigatos G. (2007). Eur J Cancer Care. 16: 433–438.
Kenne Sarenmalm E, Ohlen J, Oden A, Gaston-Johansson F. (2007). J Pain Symptom Manage. 34: 24–39.
Kenne Sarenmalm E, Ohlen J, Oden A, Gaston-Johansson F. (2008). Psychooncology. 17: 497–505.
Kenny P, King MT, Sheill A, Seymour J, Hall J, Langlsnds A, Boyages J. (2000). Breast. 9: 37–44.
Kershaw T, Northouse L, kritpracha C, Schafenacker A, Mood D. (2004). Psychol Health. 19: 139–155.
Kiebert GM, Hanneke J, de Haes CJ, Kievit J, van de Velde CJ. (1990). Eur J Cancer. 26: 1038–1042.
King MT, Kenny P, Shiell A, Hall J, Boyages J. (2000). Qual Life Res. 9: 789–800.
Kissane DW, Clarke DM, Ikin J, Bloch S, Smith GC, Vietta L, McKenzie DP. (1998). Med J Aust. 169: 192–196.
Knapp J. (1997). J Gynecol Oncol Nurs. 7: 37–40.
Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, Bontenbal M, van Pottelsberghe C, Groenvold M, Paridaens R. (2000a). Eur J Cancer. 36: 1488–1497.
Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, van Hoorebeeck I, Paridaens R. (2000b). Eur J Cancer. 36: 1498–1506.
Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R. (2000). Breast Cancer Res Treat. 64: 275–286.
Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. (2002). J Clin Oncol. 20: 4242–4248.
Land SR, Kopec JA, Yothers G, Anderson S, Day R, Tang G, Ganz PA, Fisher B, Wolmark N. (2004). Breast Cancer Res Treat. 86: 153–164.
Land SR, Wickerham DL, Costantino JP, Ritter MW, Vogel VG, Lee MK, Pajon ER, Wade JL III, Dakhil S, Lockhart JB, Wolmark N, Ganz PA. (2006). JAMA. 295: 2742–2751.
Lee EH, Chun M, Kang S, Lee HJ. (2004). Jap J Clin Oncol. 34: 393–399.
Lehto US, Ojanen M, Kellokumpu-Lehtinen P. (2005). Annal Oncol. 16: 805–816.
Lemieux J, Maunsell E, Provencher L. (2008). Psychooncology. 17: 317–328.
Levine MN, Guyatt GH, Gent M, De Pauw S, Goodyear MD, Hryniuk WM, Arnold A, Findlay B, Skillings JR, Bramwell VH. (1988). J Clin Oncol. 6: 1798–1810.
Lewis JA, Manne SL, DuHamel KN, Vickburg SMJ, Bovjerg DH, Currie V, Winkel G, Redd WH. (2001). J Behav Med. 24: 231–245.
Longman AJ, Braden CJ, Mishel MH. (1999). Oncol Nurs Forum. 26: 909–915.
Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmstrom P, Valvere V, Tennvall L, Blomqvist C. (2003). Eur J Cancer. 39: 1370–1376.
Makar K, Cumming CE, Lees AW, Hundleby M, Nabholtz J, Kieren DK, Jenkins H, Wentzel C, Handman M, Cumming DC. (1997). Can J Hum Sex. 6: 1–8.
Malinovszky KM, Gould A, Foster E, Cameron D, Humphreys A, Crown J, Leonard RC. (2006). Br J Cancer. 95: 1626–1631.
Mandelblatt J, Armetta C, Yabroff KR, Liang W, Lawreence W. (2004). J Natl Cancer Inst Monographs. 33: 8–44.
Marsden J, Baum M, A’Hern R, West A, Fallowfield L, Whitehead M, Sacks N. (2001). Br J Menopause Soc. 7: 85–87.
Martin M, Lluch A, Segui MA, Ruzi A, Ramos M, adrover E, Rodriguez-Lescure A, Grosse R, Calvo L, Fernandez-Chacon C, Roset M, Anton A, Isla D, del Prado PM, Iglesias L, Zaluski J, Arcusa A, Lopez-Vega JM, Munoz M, Mel JR. (2006). Annal Oncol. 17: 1205–1212.
Massacesi C, Sabbatini E, Rocchi MB, Zepponi L, Rossini S, Pilone A, Burattini L, Pezzoli M. (2006). Am J Cancer. 5: 433–440.
Mehnert A, Scherwatch A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U. (2007). Patient Educ Couns. 66: 108–118.
Meneses KD, McNees P, Loerzel VW, Su X, Zhang Y, Hassey LA. (2007). Oncol Nurs Forum. 34: 1007–1016.
Mills PJ, Parker B, Dimsdale JE, Sadler GR, Ancoli-Israel S. (2005). Biol Psychol. 69: 85–96.
Mols F, Vingerthoets AJ, Coebergh JW, van de Poll-Franse LV. (2005). Eur J Cancer. 41: 2613–2619.
Montazeri A, Gillis CR, McEwen J. (1996a). Eur J Cancer Care. 5: 159–167.
Montazeri A, Gillis CR, McEwen J. (1996b). Eur J Cancer Care. 5: 168–175.
Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M. (2000). Qual Life Res. 9: 177–184.
Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. (2001). Lung Cancer. 31: 233–240.
Moore FD, van de Vanter SB, Boyden CM, Lokich J, Wilson RE. (1974). Surgery. 76: 376–390.
Nissen MJ, Swenson KK, Ritz LJ, Farrell JB, Sladek ML, Lally RM. (2001). Cancer. 91: 1238–1246.
Okamura M, Yamavaki S, Akechi T, Taniguchi K, Uchitomi Y. (2005). Jpn J Clin Oncol. 35: 302–309.
Osoba D, Slamon DJ, Burchmore M, Murphy M. (2002). J Clin Oncol. 20: 3106–3113.
Palmer BV, Walsh GA, McKinna JA, Greening WP. (1980). Br Med J. 281: 1594–1597.
Pandey M, Thomas BC, Ramdas K, Eremenco S, Nair K. (2002). Qual Life Res. 11: 87–90.
Pandey M, Thomas BC, Ramdas K, Ratheesan K. (2006). Jpn J Clin Oncol. 36: 468–472.
Parker PA, Youssef A, Walker S, Basen-Engguist K, Cohen L, Gritz ER, Wei QX, Robb SL. (2007). Ann Surg Oncol. 14: 3035–3036.
Payne R, Medina E, Hampton JW. (2003). Cancer. 97 (Suppl. 1): 311–317.
Perry S, Kowalski TL, Chang CH. (2007). Health Qual Life Outcomes. 5: 24.
Priestman TJ, Baum M. (1976). Lancet. i: 899–900.
Pyszel A, Malyszezak K, Pyszel K, Andrzejak R, Szuba A. (2006). Lymphology. 39: 185–192.
Reich M, Lesur A, Perdrizet-Chevallier C. (2008). Breast Cancer Res Treat. 110: 9–17.
Richardson LC, Wang W, Hartzema AG, Wanger S. (2007). Breast J. 13: 581–587.
Ridner SH. (2005). Support Care Cancer. 13: 904–911.
Rietman J, Dijkstra P, Debreczeni R, Geertzen J, Robinson D, de Vries J. (2004). Disabil Rehabil. 26: 78–84.
Rietman JS, Dijkstra PU, Hoekstra HJ, Eisma WH, Szabo BG, Groothoff JW, Geertzen JH. (2003). Eur J Surg Oncol. 29: 229–238.
Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU. (2006). Eur J Surg Oncol. 32: 148–152.
Roth RS, Lowery JC, Davis J, Wilkins E. (2005). Plast Reconstr Surg. 116: 993–1002.
Schou I, Ekeberg O, Sandvik L, Hjermstad MJ, Ruland CM. (2005). Qual Life Res. 14: 1813–1823.
Schreier AM, Williams SA. (2004). Oncol Nurs Forum. 31: 127–130.
Schults PN, Klein MJ, Beck ML, Stava C, Sellin RV. (2005). J Clin Nurs. 14: 204–211.
Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M. (1995). J Natl Cancer Inst. 187: 1316–1322.
Shimozuma K, Okamoto T, Katsumata N, Koike M, Tanaka K, Osumi S, Saito M, Shikama N, Watanabe T, Mitsumori M, Yamauchi C, Hisashige A. (2002). Breast Cancer. 9: 196–202.
Shimozuma K, Sonoo H, Ichihara K, Tanaka K. (2000). Surg Today. 30: 255–261.
Spagnola S, Zabora J, BrintzenhofeSzoc K, Hooker C, Cohen G, Baker F. (2003). Breast J. 9: 463–471.
Spiegel D. (1997). Semin Oncol. 24 (Suppl. 1): S36–S47.
Spiegel D. (2001). J Psychosom Res. 50: 287–290.
Sprangers MAG, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK. (1996). J Clin Oncol. 14: 2756–2768.
Stein KD, Jacobsen PB, Hann DM, Greenberg H, Lyman G. (2000). J Pain Symptom Manage. 19: 436–445.
Stewart BW, Paul Kleihues P. (2003). World Cancer Report. International Agency Research on Cancer, Lyon, France.
Velanovich V, Szymanski W. (1999). Am J Surg. 177: 184–187.
Wan C, Tang X, Tu XM, Feng C, Messing S, Meng Q, Zhang X. (2007b). Breast Cancer Res Treat. 105: 187–193.
Wan C, Zhang D, Yang Z, Tu X, Tang W, Feng C, Wang H, Tang X. (2007a). Breast Cancer Res Treat. 106: 413–418.
Wonghongkul T, Dechaprom N, Phumivichuvate L, Losawatkul S. (2006). Cancer Nurs. 29: 250–257.
Yen JY, Ko CH, Yen CF, Yang MJ, Wu CY, Juan CH, Hou MF. (2006). Psychiatry Clin Neurosci. 60: 147–153.
Yun YH, Bae SH, Kang IO, Shin KH, Lee R, Kwon SI, Park YS, Lee ES. (2004). Support Care Cancer. 12: 441–445.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Appendix
Appendix
1.1 Some Key Facts About Breast Cancer
-
The most common sign of breast cancer is a new lump or mass. A lump that is painless, hard, and has uneven edges is more likely to be cancer. Sometimes cancers can be tender, soft, and rounded. Other signs of breast cancer include a swelling of part of the breast; skin irritation or dimpling; nipple pain or the nipple turning inward; redness or scaliness of the nipple or breast skin; a nipple discharge (other than breast milk); and a lump in the under arm area.
-
The cause of breast cancer is not known. Factors that can increase a woman’s risk include heredity, early puberty, late childbearing, obesity, and lifestyle factors such as heavy alcohol consumption and smoking. The biggest risk factor for breast cancer is age that is growing older. Most breast cancers occur in women over the age of 50, and women over 60 are at the highest risk.
-
A woman’s risk for developing breast cancer increases if her mother, sister, daughter, or two or more other close relatives, such as cousins, have a history of breast cancer, especially at a young age. However, 85% of women who develop breast cancer have no known family history of the disease.
-
Changes in certain genes (BRCA1, BRCA2, and others) make women more susceptible to breast cancer. Genetic testing can determine whether a woman has these abnormal genes.
-
Based on involvement of breasts, breast cancer can be categorized as stage 0 (cancer cells remain in the breast duct), stage I (cancer is 2 cmentimeters or less), stage II (tumor is over 2 but not larger than 5 cm or is spread to the lymph nodes under the arm), stage III or locally advanced (tumor is more than 5 cm or is extensive in the under arm lymph nodes or spread to other lymph nodes or tissues near the breast) and stage IV (cancer has spread or metastasized to other parts of the body).
-
5-year survival time for breast cancer patients vary depending on stage and treatment received. However, there are differences between survival for the same breast cancer patients in developed and developing countries.
Source: adapted from www.breastcancer.org
1.2 Breast Cancer Treatment Options
-
Surgery is the treatment of choice for breast cancer. There are different surgery options for breast cancer: breast conservation surgery and mastectomy.
-
In breast conservation surgery we save the breast and it includes: lumpectomy (malignant tumor and a rim of normal tissue are removed) or quadrantectomy (malignant tumor and a large rim of normal tissue are removed) with axillary dissection.
-
In mastectomy the whole breast is removed and it includes: total or simple mastectomy (whole breast is removed); or modified radical mastectomy (the whole breast is removed with under arm lymph nodes); or radical mastectomy (the whole breast, chest muscles, all lymph nodes under the arm, and some additional fat and skin are removed).
-
Chemotherapy uses drugs to destroy cancer cells. It is given systemically (throughout the body) after surgery to kill cancer cells that may have been left behind (adjuvant therapy). Also it may be given before surgery to reduce the size of the cancer (neoadjuvant therapy).
-
Hormonal therapy is a form of whole body (systemic) treatment for breast cancer. In hormonal therapy, drugs are used to reduce or block the effects of hormones (including estrogen and progesterone) that can promote the growth of breast cancer. Hormonal therapy protects the whole body from breast cancer cells that may have been left behind after surgery, radiation, or chemotherapy. It can also lower the risk of a new cancer developing in the other breast.
Source: adapted from www.breastcancer.org
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Montazeri, A. (2010). Quality of Life in Breast Cancer Patients: An Overview of the Literature. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_165
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_165
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine